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Abstract
Background: Uterine fibroids (UFs) are the most common benign tumour in women, and many undergo
hysterectomy or uterus-preserving procedures (UPPs) to manage their symptoms. We aimed to validate the
recording of UFs in a primary care database, The Health Improvement Network (THIN), and to determine the
incidence of UFs in the UK.
Methods: In this observational study, women in THIN aged 15–54 years between January 2000 and December
2009 with no previous record of UFs, hysterectomy or UPPs were identified. Individuals were followed up until
there was a Read code indicating UFs, they reached 55 years of age or died, or the study ended. Among those
without a UF code, women were identified with a code for hysterectomy, UPPs or heavy menstrual bleeding (HMB).
Anonymized patient profiles from each category were randomly selected and reviewed. Subsequently, primary care
physicians were asked to complete questionnaires to verify the diagnosis for a randomly selected subgroup.
Results: In total, 737,638 women were identified who met the initial inclusion criteria. The numbers of women with
a code for UFs, hysterectomy, UPPs and HMB were 9380, 11,002, 3220 and 60,915, respectively; the proportions of
confirmed cases of UFs were 88.8, 29.7, 57.7 and 15.9 %. The estimated number of women with UFs was 23,140 (64.
0 % without a recorded UF diagnosis). The overall incidence of UFs was 5.8 per 1000 woman-years.
Conclusions: UFs were confirmed in a high proportion of women with UF Read codes. However, almost two-thirds
of cases were identified among women with a code for hysterectomy, UPPs or HMB. These results show that UFs
are under-recorded in UK primary care, and suggest that primary care physicians tend to code the symptoms of
UFs more often than the diagnosis.
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Background
The frequency of uterine fibroids (UFs) in the general
population is difficult to quantify because many women
with UFs are asymptomatic [1]. Ultrasound examination
of over 1000 randomly selected members of an urban
health plan in the USA demonstrated that approximately
half of premenopausal women with no previous diagno-
sis of UFs had evidence of UFs [2]. Analysis of 2500 con-
secutive hysteroscopies, of women aged 19–82 years
revealed that almost one-quarter had UFs [3]. Similarly,
examination of over 2000 consecutive pelvic ultrasound
scans showed that 29.9 % of these women, aged 11–96
years, had UFs [4]. Heavy menstrual bleeding (HMB) is
common in women with UFs [5], and diagnostic studies
have detected UFs in approximately 30 % of women with
HMB [3, 6]. Women with UFs may also suffer from bulk
symptoms such as urinary incontinence/retention, bowel
disturbance and pain [5]. The symptoms of UFs can have
a severe impact on quality of life, and in some countries
the presence of UFs is the most common indication for
hysterectomy [7]. Patients who do not wish to undergo
hysterectomy to treat UFs may opt for procedures that
preserve uterine integrity such as myomectomy and
uterine artery embolization, specifically used to treat
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UFs, and endometrial ablation, which is used mainly for
the treatment of HMB [8].
For most patients with UFs, the point of entry into the
UK healthcare system is a consultation with a primary
care physician (PCP). The Health Improvement Network
(THIN) is one of the largest national collections of data
from primary care, containing anonymized patient infor-
mation recorded by PCPs as part of routine clinical care.
Symptoms, diagnoses and procedures are recorded using
Read codes, and PCPs can provide additional informa-
tion in free-text entries [9]. THIN also contains details
of referrals to specialists, and diagnoses associated with
these consultations may be entered retrospectively by
PCPs, using Read codes or free-text comments. With
the availability of multiple Read codes, there can be con-
siderable variation in how PCPs record information, and
previous studies have identified the need for bespoke
search strategies that reflect the clinical and coding defi-
nitions in use [10]. For example, a study of the use of
Read codes in diabetes mellitus management revealed
that 25 different codes were reported in the 17 practices
examined [11]. The aim of our study was to validate the
recording of UFs in THIN, and to estimate the incidence
of UFs in the UK general population.
Methods
Data source
THIN is a longitudinal research database containing
data from over 3 million active patients currently reg-
istered with participating UK general practices [12].
The patients in THIN are representative of the UK
population with respect to demographics and the
prevalence of major conditions [13].
Study design
A cohort of women aged 15–54 years between January
2000 and December 2009 were identified who met the
following criteria: enrolled for at least 5 years with their
PCP, had a computerized prescription history for at least
3 years, and had consulted with their PCP at least once
in the past 3 years (Fig. 1).
Given that myomectomy and uterine artery
embolization are used solely in the treatment of UFs,
women with a code for these procedures were classified as
having a code for UF diagnosis. Potential UF treatments,
such as endometrial ablation and uterine surgeries, were
categorized under uterus-preserving procedures (UPPs).
The complete list of the Read codes used can be found in
Additional file 1: Table S1. The routine use of magnetic
resonance image-guided focused ultrasound ablation for
the treatment of UFs was not approved by the National
Institute for Health and Care Excellence until 2011, so
was not examined in this study [14].
Women with a Read code for UFs, hysterectomy or
UPPs before the start date were excluded. Women were
followed up until a Read code indicative of UFs was re-
corded, they reached 55 years of age or died, or the
study ended. Subsequently, among women without a UF
code, searches were conducted for codes for hysterec-
tomy or UPP. Finally, a search was conducted for
women with HMB who did not have a Read code for
UFs, hysterectomy or UPPs.
Validation of incident UF cases identified by a UF code
The records of a random sample of 500 women with
Read codes indicative of UFs were examined, by one re-
searcher, for free-text entries that were associated with
Fig. 1 Outline of the study design. Myomectomy and uterine artery embolization are used solely for the treatment of UFs and were classified as
specific UF codes. Read codes that indicated other surgeries of the uterus or endometrial ablation were classified as uterus-preserving procedures.
PCP, primary care physician; THIN, The Health Improvement Network; UF, uterine fibroids
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codes for gynaecological conditions recorded at any time
during the patient’s medical history. These records were
also searched for comments attached to any consultation
occurring within 1 month of recording the UF code.
This could include additional information derived from
referral letters, test results or diagnostic procedures such
as ultrasound scan, hysteroscopy, laparoscopy or phys-
ical examination.
After manual review of all records, cases were assigned
as probable cases (incident UF diagnosis) or non-cases
(confirmed by free-text comments as negative UF diag-
noses, such as adenomyosis, polyps or other leiomyoma,
or prevalent cases, i.e. cases diagnosed in the past). Most
probable cases of UFs were confirmed by free-text com-
ments that referred to UF characteristics (including size,
number, localization or type) or by comments related to
the UFs diagnosis (e.g. confirmation by ultrasound scan
or noted during pregnancy). Patients without free-text
comments specifically excluding or confirming the diag-
nosis of UFs were retained as probable cases.
In a subsequent step, questionnaires were sent to the
PCPs of 200 patients randomly sampled from this sub-
group of 500 women. PCPs were requested to confirm or
refute the diagnosis of UFs, and were also asked to send a
copy of all UF-related information, including test results
and diagnostic procedures. The proportion of women with
incident UFs among those originally assigned as probable
cases or non-cases was then determined.
Validation of incident UF cases among women with a
code for hysterectomy, UPPs or HMB
The profiles of a random selection of 200 women with-
out UF codes but with codes for hysterectomy (149 re-
cords) or UPPs (51 records) were reviewed. Among
those without a code for UFs, hysterectomy or UPPs,
profiles of women with a code for HMB (200 records)
were also reviewed. For a random sample of women
from each of these three cohorts, questionnaires were
sent to their PCPs requesting confirmation of whether
or not the presence of UFs was the indication for the
hysterectomy, UPP or HMB (or indicating the real cause
otherwise). Questionnaires were sent to 50, 10 and 50
PCPs of women in the hysterectomy, UPP and HMB co-
horts, respectively. For each cohort, the proportion of
women with incident UFs among those originally
assigned as probable cases or non-cases was determined.
Estimation of incidence of UFs
The incidence of UFs was determined by dividing the
number of women with Read codes for UFs by the total
person-years contribution to first follow-up. This calcu-
lation was performed for the overall study population
and for each 5-year age group of women aged 15–54
years. The corrected overall incidence of UFs included
the estimated number of women with incident UFs
among the cohorts with Read codes for hysterectomy,
UPP or HMB, in addition to those with Read codes for
UFs.
Results
In total, 737,638 women were identified who met the
initial criteria. The age distribution of the study cohort
can be found in Additional file 2: Table S2. After a mean
follow-up of 5.4 years, (almost 4 million person-years),
9431 women had a Read code indicating a diagnosis of
UFs. Following exclusion of 51 cases in which the code
was not specific to leiomyomas of the uterus, 9380
women with potential incident UFs were identified. The
incidence of recorded UFs increased with age, peaking
in the group aged 45–49 years (Fig. 2). Most cases of in-
cident UFs (n = 7696, 82.4 %) were diagnosed in women
aged 40–54 years. The numbers of women identified
with a Read code for hysterectomy, UPPs and HMB
were 11,002, 3220 and 60,915, respectively.
Validation of incident UF cases identified by a UF code
In our sample of 500 patient profiles with Read codes in-
dicative of a UFs diagnosis, 470 (94.0 %) were classified
as probable incident cases of UFs following assessment
of free-text comments (Table 1). The remaining 30
women (6.0 %) included 21 prevalent cases of UFs and
nine women with diagnoses other than UFs. In the sec-
ond validation step, of the 200 questionnaires sent, 186
valid questionnaires were received from PCPs. Of these,
176 were for patients who had been classified as
Fig. 2 Incidence of uterine fibroids according to age group in
women with a Read code for uterine fibroids
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probable UFs cases in the initial step; 164 patients were
confirmed as having incident UFs (confirmation rate,
93.2 %). Ten valid questionnaires were returned for
women who were originally classified as non-UF cases;
two (20.0 %) of these were revealed as incident cases of
UFs. The weighted percentages of these confirmation
rates were 87.6 and 1.2 % in probable and non-UF cases,
respectively.
Taking the weighted sum of these confirmation rates,
the proportion of women correctly identified by Read
codes (i.e. the positive predictive value) was 88.8 %.
Based on this, the total estimated number of incident
cases of UFs within the cohort was 8329, with a corre-
sponding incidence of 2.1 per 1000 woman-years.
Validation of incident UF cases among women with a
code for hysterectomy
Among the sample of 149 individuals with a Read code
for hysterectomy, the index event was confirmed in
92.6 % of women by analysis of free-text comments
(Table 1). From a total of 37 valid PCP questionnaires,
diagnosed UFs were confirmed in 11 cases. Of these, 10
were among women originally classified as probable UFs
cases. After weighting, it was estimated that 3268
women (29.7 % of women with a Read code for hysterec-
tomy) had incident UFs.
Validation of incident UF cases among women with a
code for UPPs
From review of free-text comments in patient profiles
from 51 cases of UPPs, 92.3 % of cases were confirmed
as probable UPPs (Table 1). From the nine PCP ques-
tionnaires received, five cases of incident UFs were
reported (one in free-text entries), all in probable cases
of UFs (62.5 %). After weighting, it was estimated that
1858 women (57.7 % of women with a code for UPPs)
had incident UFs.
Validation of incident UF cases among women with a
code for HMB
Of the 200 patient profiles that were manually reviewed,
173 (86.5 %) were classified as probable HMB (Table 1)
on the basis of the free-text comments. Among the 44
valid PCP questionnaires received, UFs were confirmed
for seven patients. All of the confirmed cases were
among those originally classified as probable UFs cases
(18.4 %). After weighting, UFs were estimated to be
present in 9685 women (15.9 %) with HMB.
Corrected incidence of UFs
Based on these calculations, it was estimated that there
were 23,140 women with incident UFs in THIN during
2000–2009. The overall incidence of UFs was 5.8 per
1000 woman-years among women aged 15–54 years.
Discussion
Our study showed that among women with a code indi-
cating UFs, the proportion correctly recorded was
88.8 %, highlighting the high predictive power of Read
codes in this instance. This figure compares favourably
with those from other studies [15]. It was estimated,
however, that only about one-third of cases were identi-
fied on the basis of a specific Read code for the diagnosis
of UFs. There is considerable variation in the reliability
of the recording of patient information in primary care.
As might be expected, conditions with subjective
Table 1 Determination of incident cases of uterine fibroids in The Health Improvement Network database















Number of records 500 149 51 200








176 10 34 3 8 1 38 6
Incident cases
of UFs
164 (93.2 %) 2 (20.0 %) 10 (29.4 %) 1 (33.3 %) 5 (62.5 %) 0 (0 %) 7 (18.4 %) 0 (0 %)
Weighted percentage of confirmation rates 87.6 % 1.2 % 27.2 % 2.5 % 57.7 % 0 % 15.9 % 0 %
Combined total (proportion of women
correctly identified by Read codes)
88.8 % 29.7 % 57.7 % 15.9 %
Cohort size 9380 11,002 3220 60,915
Estimated number of incident cases in
the cohort
8329 3268 1858 9685
PCP primary care physician, UFs uterine fibroids
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diagnostic criteria, such as asthma, have a lower quality
of recording than conditions with specific clinical char-
acteristics, such as diabetes mellitus [16]. It has been
recommended that in the analysis of data from primary
healthcare databases, the reliability of the recording of
each condition being studied should be validated [17].
Based on the total estimated number of UFs cases
identified using Read codes for UFs, hysterectomy, UPP
and HMB, the incidence of UFs was 5.8 per 1000
woman-years. It is worth noting that this estimate re-
flects the incidence of clinically relevant UFs, or those
found incidentally during procedures for other reasons.
Given that many women with UFs remain asymptom-
atic, this is likely to be an underestimate of the true inci-
dence of the condition [18, 19].
To the best of our knowledge there have previously
been no figures available for the incidence of UFs in the
UK. The figure determined in our study is similar to
that from an analysis of the healthcare records of
women in the US armed forces, in which an incidence
of 57.6 per 10,000 person-years was calculated [20]. In
another US study, however, the age-standardized inci-
dence of self-reported UFs, confirmed by examination
or following hysterectomy, was 8.9 per 1000 woman-
years among Caucasian women and 30.6 per 1000
woman-years among African-American women [21].
Ethnicity is not systematically recorded in THIN, but
the incidence determined in our study may be lower
than that obtained from self-reporting. Furthermore,
between the menarche and the menopause, the inci-
dence of UFs increases with age, and the incidence of
UFs in a study population will be dependent on the age
distribution of the women. Although THIN has been
shown to be representative of the UK population [13],
there may be small differences between the age distri-
bution of the women eligible for this study and those in
the whole UK population.
One limitation of our study is that potential unrecorded
cases of UFs were sought only among women with the
most common symptom of UFs, HMB. A search strategy
that included women who had consulted their PCP about
other gynaecological symptoms potentially related to UFs,
such as dysmenorrhoea or bulk symptoms, might have
identified further cases. Our study, however, already used
four search strategies that included a total of 140 Read
codes, and it is likely that further searches would have
returned a low rate of additional confirmed cases. Another
potential approach to identify women with UFs would be
to search prescribing data, which are recorded in THIN
using Multilex codes [22]. During the study period, how-
ever, the only medical therapies licensed for the treatment
of UFs in the UK (gonadotropin-releasing hormone ana-
logues and ulipristal acetate) were indicated for preopera-
tive therapy, and it is likely that any women prescribed
these treatments would have already been identified by the
existing searches. It must also be kept in mind that the in-
complete response to questionnaires sent to PCPs could
have affected the confirmation rates of UF cases. If a sub-
stantial proportion of the questionnaires that were not
returned related to non-cases of UFs, the true incidence
may be lower than the reported estimate. However, we
believe that any such effects are likely to be minor, on the
basis that the response rate to PCP questionnaires was al-
most 90 %. Moreover, there is no reason to indicate that re-
sponders and non-responders differed in terms of the
proportion of confirmed UFs cases.
There are other examples of searches using Read
codes that had low sensitivities. In studies of electronic
health records, fewer than two-thirds of patients with
diabetes mellitus were correctly identified using the
specific code ‘C10 Diabetes mellitus,’ and only 17 % of
patients with active seasonal allergic rhinitis could be
identified on the basis of a specific Read code [10, 11].
Furthermore, the practice of recording body mass
index rather than a diagnosis of obesity resulted in
only 2.1 % of patients with obesity being identified
using a specific Read code [15]. These examples reflect
the diversity of the recording practices used by PCPs,
rather than inherent problems with Read codes. In our
study, and in other cases in which a similar approach
has been taken, an expanded search strategy resulted
in an increase in the estimated absolute number of
patients with the outcome of interest. There is still,
however, potential for some underestimation of the in-
cidence of UFs. We estimated that in THIN, there
were more cases of UFs present among women with a
record of HMB than among those with a UF Read
code. This suggests that for women with UFs, PCPs
tend to record the symptoms or the procedures under-
taken rather than the diagnosis. Most UFs are detected
by ultrasound examination and, in the UK, PCPs do
not typically have direct access to ultrasonography.
Normally, diagnoses of UFs would be communicated
to PCPs by specialists, but this information might not
be recorded in THIN using Read codes. These factors
may contribute to the apparent practice of PCPs re-
cording symptoms rather than the diagnosis. Recently,
the Fédération Internationale de Gynécologie et d’Ob-
stétrique developed guidelines for the nomenclature
and classification of causes of abnormal uterine bleed-
ing [23]. The ‘PALM-COEIN’ classification system,
which includes a sub-classification system for UFs, was
designed to assist clinicians in the evaluation of pa-
tients. The widespread adoption of this system may
help the future study of UFs by encouraging PCPs to
record the suspected cause of HMB. New Read codes
are released periodically by the National Health Service
Information Authority, and it is important that this
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new classification system is considered in the develop-
ment of future codes.
Conclusions
The incidence of UFs in the UK was 5.8 per 1000 woman-
years, as determined by the analysis of medical records.
Only about one-third of women with UFs in THIN could
be identified using a Read code indicating the diagnosis of
UFs. These results show that UFs are under-recorded in
THIN and suggest that PCPs tend to code the symptoms
of UFs more often than the diagnosis.
Additional files
Additional file 1: Table S1. Read codes indicative of uterine fibroids.
This table presents a complete list of the Read codes used to identify
potential cases of uterine fibroids in THIN database. The list of Read
codes includes specific codes for uterine fibroids, codes for hysterectomy
and uterus preserving procedures, as well as codes for heavy menstrual
bleeding. (DOCX 18 kb)
Additional file 2: Table S2. Age distribution of women in the study
cohort. This table presents the age distribution of the 737,638 women in
the study cohort. Women are grouped into eight age categories (15–19,
20–24, 25–29, 30–34, 35–39, 40–44, 45–49 and 50–54). (DOC 28 kb)
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